Ovarian Cancer: Another Promising Target for Liquid Biopsy
A blood test to screen for ovarian cancer is one of many new liquid biopsy assays being evaluated to screen for cancer.
Source: medscape.com
📰 Delfi Diagnostics News
Delfi Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Delfi Diagnostics. Real-time updates on events, politics, business and more.
City of Hope and DELFI Diagnostics announce collaboration to improve lung cancer screening rates in underserved areas of Los Angeles
/PRNewswire/ -- City of Hope, one of the largest cancer research and treatment organizations in the United States, and DELFI Diagnostics, Inc., a developer of...
Source: prnewswire.com
DELFI Diagnostics Supports Proposed Legislation to Allow CMS to Review New Blood-Based Screening Tests for Lung Cancer
/PRNewswire-PRWeb/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to enhance cancer detection, today announced...
United States Larry Bucshonr Indiana Victor Velculescu Derek Kilmerd Washington Vern Buchananr Florida Centers For Medicare Medicaid Services
Source: prnewswire.com
Cancer Biopsy Market Surpass $67.11 billion by 2030 - Exclusive Report by Coherent Market Insights
/PRNewswire/ -- According to Coherent Market Insights, The global cancer biopsy market was valued at US$ 25.61Billion in 2023 and is forecast to reach a value...
Source: prnewswire.com
Liquid biopsies could be used as an early marker of immunotherapy response, study finds
Liquid biopsies are blood tests that can serially measure circulating tumor DNA (cell-free DNA that is shed into the bloodstream by dying cancer cells).
Source: news-medical.net
DELFI Diagnostics to Highlight Breakthrough Technology and Completed Clinical Study in Lung Cancer Detection
/PRNewswire/ -- DELFI Diagnostics, Inc., a developer of accessible blood-based tests that deliver a new way to detect cancer, announced today that the company...
Source: prnewswire.com
Machine Learning Blood Test Detects Cancers with Genome-Wide Mutations in Single Molecules of Cell-Free DNA
Novel blood testing technology being developed by researchers at the Johns Hopkins Kimmel Cancer Center that combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning may allow earlier detection of lung and othe
Source: indiaeducationdiary.in
Deep-learning technology could help scientists to develop personalized immunotherapies and vaccines
Deep-learning technology developed by a team of Johns Hopkins engineers and cancer researchers can accurately predict cancer-related protein fragments that may trigger an immune system response.
United States San Diego Benjamin Alexander Albert Johns Hopkins Valsamo Elsa Anagnostou Rachel Karchin
Source: news-medical.net
Factors Associated With Lung Cancer Risk Factor Documentation
This cross-sectional observational study found several factors associated with whether a patient had sufficient lung cancer risk factor documentation in the electronic health record.
United States University Of Washington New York Fred Hutchinson Cancer Research Center United Kingdom Healthc Amst
Source: ajmc.com
DELFI Diagnostics Presents Additional Promising Proof-of-Concept Data on its Monitoring Program at AACR 2023
/PRNewswire/ -- DELFI Diagnostics, Inc., a pioneering developer of a new class of high-performance, accessible liquid biopsy tests for early cancer detection...
United States Nicholos Dracopoli Peter Bach Diagnostics Inc American Association For Cancer Research Netherlands Cancer Institute
Source: prnewswire.com